Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Attractive Growth Projected in RNAi Market - Invitrogen and Applied Biosystems Revealed as Leading Suppliers in New Life Science Dashboard(TM) From Percepta Associates.


CARLSBAD, Calif. -- Today Percepta Associates launched its Gene Silencing Life Science Dashboard[TM] market research report revealing market growth rates Growth Rates

The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures.

Notes:
Remember, historically high growth rates don't always mean a high rate of growth looking into the future.
 of between 11% and 30% for gene silencing methodologies. This new Dashboard presents key market indicators for the gene silencing market as a whole as well as for the following methods representing market sub-segments:

* RNAi screens using siRNA libraries

* Inducing siRNAs in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body.

in vi·vo
adj.
Within a living organism.



in vivo adv.
 from a plasmid or other vector in cells

* Delivering synthetic siRNAs into cells

* Digesting long dsRNA in vivo using dicer dic·er  
n.
A device used for dicing food.

Noun 1. dicer - a mechanical device used for dicing food
mechanical device - mechanism consisting of a device that works on mechanical principles
 or other enzymes

* Expressing siRNA in vitro for delivery into cells

* Using PCR PCR polymerase chain reaction.

PCR
abbr.
polymerase chain reaction


Polymerase chain reaction (PCR) 
 mediated siRNA expression cassettes to generate siRNAs

* Delivering siRNAs into cells by transfection trans·fec·tion
n.
Infection of a bacterium or cell with DNA or RNA isolated from a bacteriophage or from an animal or a plant virus, resulting in replication of the complete virus.
 

* Delivering siRNAs into cells by electroporation electroporation (i·lekˈ·trō·p·rāˑ·sh  

* Delivering siRNAs into cells by viral infection

* Using a reporter systems to track gene knockdown

RNA interference (RNAi) is rapidly emerging as an integral tool for investigating the physiological function of genes. RNAi -based methods allow researchers to modulate, and in many cases effectively silence, expression of a gene of interest. Systems for delivering RNAs into cells for the purpose of gene silencing include standard transfection technologies as well as plasmid and viral systems for the inducible expression of siRNAs in vivo.

The Gene Silencing Dashboard shows Applied Biosystems (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother.


(Application Binary Interface) A specification for a specific hardware platform combined with the operating system.
), primarily with its Ambion products, and Invitrogen (NASDAQ:IVGN) to be among the top suppliers for all ten categories surveyed. Other companies recognized as leaders in specific segments include Dharmacon (NYSE NYSE

See: New York Stock Exchange
:TMO TMO T-Mobile
TMO The Mac Observer (website)
TMO Timeout (Hekimian)
TMO Tenant Management Organisation (UK)
TMO Toprak Mahsulleri Ofisi
), Qiagen (NASDAQ:QGENF) and Amaxa Biosystems.

This new gene silencing market report from Percepta Associates, a market research and strategic consulting firm focused on serving life science companies, was developed from responses to a 36-question survey by over 360 scientists predominantly located in North America and Europe.

"The gene silencing market is one of the most rapidly growing markets served by life science tool companies," said Scott Provost, Principal of Percepta. "However, it's an increasingly competitive market. This Dashboard report will help companies currently serving the gene silencing segments, as well as those planning entry, to quickly assess where opportunities for growth and share gain lie."

To view RNAi market research sample data and questionnaires visit: http://www.perceptaassociates.com/publications/ gene_silencing_sample.shtml (Due to its length, this URL URL
 in full Uniform Resource Locator

Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program.
 may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)

Life Science Dashboards[TM] are readily accessible sources of current, segment-specific, market research. Designed and implemented by industry veterans, each dashboard provides key life science market indicators compiled from the survey responses of hundreds of qualified decision-makers and researchers actively using molecular biology and cell culture products.

Unlike other market research reports, Percepta's dashboards feature an at a glance format that provides rapid access to actionable key market indicators in an easy to understand framework, including:

* Market size

* Market share

* Market growth and reaction throughput rates

* Customer satisfaction

* Propensity to switch

* Competitive intensity

* Perceived pricing

* Top suppliers

* Technique usage frequency

* Fastest growing techniques

* Primary and secondary downstream applications

About Percepta

Founded in 2005 in Carlsbad, Percepta Associates serves an impressive and rapidly growing roster of bioscience clients across North America and Europe. Percepta is a specialized consultancy providing expert market research, strategic business planning, portfolio management, product and corporate branding and marketing communications services. For more information visit http://www.perceptaassociates.com
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 19, 2007
Words:550
Previous Article:Quanta Services to Acquire InfraSource Services in All-Stock Transaction.
Next Article:BBN Technologies Awarded $.9M to Advance State-of-the-Art in Automatic Video Understanding.



Related Articles
APPLIED BIOSYSTEMS/MILLIPORE FUND UNIV. OF TOKYO PROTEOMICS.
Invitrogen Receives the Frost & Sullivan Excellence in Research Award for its RNAi Design Algorithm.
Invitrogen Corporation Expands Proteomics Capabilities with Launch of Mass Spectrometry Solutions and Co-Marketing Agreement with Applied Biosystems.
Invitrogen, Procter & Gamble Extend Research Agreement; Successful RNAi Research Service Agreement Continues with Two Year Extension.
Invitrogen Introduces Stealth(TM) RNAi Human Kinase Collection; First Chemically Modified RNAi Collection to Human Protein Kinases for...
Invitrogen Enters into Worldwide Co-Marketing Agreement with genOway Focused on RNAi Services; Deal Positions Companies to Address in vivo Target...
Open Biosystems Helps Drexel University ''Knock Out'' Genes Associated with Alzheimer's Disease; Drexel's RNAi Resource Center Relies on Open...
What are the Main Types of RNAi-testing Technologies that are Currently Available?
Percepta Launches Life Science Dashboard(TM) Market Research Reports for Purification, Amplification & Transfection.
Affymetrix Dominates Microarray Segment; Applied Biosystems Leads Real-Time PCR Segment in Nearly $1 Billion Gene Expression Profiling Market.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles